![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
1 Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Department of Health, Education and Welfare, Bethesda, Maryland
Following administration of tyramine-H3 or m-tyramine-H3 the 
-hydroxylated derivatives of these amines, octopamine-H3 and m-octopamine -H3, are rapidly formed in the heart and salivary gland. Formation of the - hydroxylated derivatives is enhanced by inhibition of monoamine oxidase, but 
-methyloctopamine-H3 formation from -methyltyramine-H3 is uninfluenced. Octopamine-H3 formation and endogenous octopamine accumulation after monoamine oxidase inhibition are largely prevented by chronic sympathetic denervation. Octopamine in tissues is released by sympathetic nerve stimulation, but this amine is relatively inactive. The hypothesis is proposed that the partial sympathetic blockade observed after chronic inhibition of monoamine oxidase or after administration of large doses of tyramine may be the consequence of replacement of norepinephrine by a false, inactive neurochemical transmitter.
This article has been cited by other articles:
|
|
 |
|
  G. K. Aghajanian, A. W. Graham, and M. H. Sheard Serotonin-Containing Neurons in Brain: Depression of Firing by Monoamine Oxidase Inhibitors Science, September 11, 1970; 169(3950): 1100 - 1102. [Abstract] [PDF]
|
|
|
|
|
|
P. Molinoff and J. Axelrod Octopamine: Normal Occurrence in Sympathetic Nerves of Rats Science, April 25, 1969; 164(3878): 428 - 429. [Abstract] [PDF]
|
|
|
|
 |
|
 A. D. Bender The Hemodynamics of Hypertension and Anti Hypertensive Therapy Angiology, September 1, 1966; 17(9): 627 - 639. [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
